Senores Pharmaceuticals Limited (NSE:SENORES)

India · Delayed Price · Currency is INR

1,315.00

-0.40 (-0.03%)

Jun 19, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Pharmaceuticals	6.33B	3.98B	2.15B	353.37M	141.70M
Pharmaceuticals Growth	58.85%	85.65%	507.07%	149.38%	-
Total	6.33B	3.98B	2.15B	353.37M	141.70M
Total Growth	58.85%	85.65%	507.07%	149.38%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	1.05B	474.30M	55.09M	58.33M
India Growth	121.21%	760.95%	-5.55%	-
outside India	2.93B	1.67B	298.28M	83.37M
outside India Growth	75.55%	460.18%	257.78%	-
Total	3.98B	2.15B	353.37M	141.70M
Total Growth	85.65%	507.07%	149.38%	-